
AbbVie expands biologics manufacturing capacity with a $223 million investment in Singapore manufacturing site | Singapore EDB
AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 million) expansion of its Singapore manufacturing facility. This

